Merck (MRK) Tops Q4 EPS by 1c

Merck (NYSE: MRK) reported Q4 EPS of $0.87, $0.01 better than the analyst estimate of $0.86. Revenue for the quarter came in at $10.48 billion versus the consensus estimate of $10.61 billion.

Merck sees FY2015 EPS of $3.32-$3.47, versus the consensus of $3.49.

For earnings history and earnings-related data on Merck (MRK) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Femasys Inc. (FEMY) Misses Q2 EPS by 20c
• Greenlane Holdings Inc. (GNLN) reported Q2 result